Rhythm Pharmaceuticals, Inc.
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent…
Biotechnology
US, Boston [HQ]
RYTM/Leadership and Strategy
Risk Factors
Annual
Not Available
No Risk Factor available yet. You can request "Risk Factors" through an email.
Quarter
Not Available